The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis

Zhenyue Hao(Princess Margaret Cancer Centre), Tak W. Mak(University Health Network), Han You(Xiamen University), Michael Reth(University of Freiburg), Jennifer Silvester(Ontario Institute for Cancer Research), Elias Hobeika(Max Planck Institute of Immunobiology and Epigenetics), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Chiara Gorrini(Princess Margaret Cancer Centre), Wanda Y. Li(Ontario Institute for Cancer Research), Claire Hong(Ontario Institute for Cancer Research), Qing Zhong(Shanghai Ninth People's Hospital), Jacqui Detmar(Mount Sinai Hospital), Susan McCracken(Kettering University), Qinxi Li(Xiamen University), Pamela S. Ohashi(University Health Network), Andrea Jurisicova(University of Toronto), Andrew Elia(Ontario Institute for Cancer Research), Dirk Brenner(University of Luxembourg), Xiaodong Wang(Shanghai Children's Medical Center), Yu-Wen Su(National Central University), Yi Sheng(York University), Gordon S. Duncan(Ontario Institute for Cancer Research), Annick You-Ten(Ontario Institute for Cancer Research), Philipp A. Lang(Heinrich Heine University Düsseldorf)
The Journal of Experimental Medicine
January 2, 2012
Cited by 65


Related Papers